Baudo f pubblicazioni

Dr. Francesco Baudo – Pubblicazioni scientifiche 1. Baudo F, Caimi T, de Cataldo F. Diagnosis and treatment of acquired haemophilia. Haemophilia. 2. Collins P, Baudo F, Huth-Kühne A, Ingerslev J, Kessler CM, Castellano ME, Shima M, St-Louis J, Lévesque H. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010 Jun 7;3:161. 3. Toschi V, Baudo F Diagnosis, laboratory aspects and management of acquired hemophilia A. Intern Emerg Med. 2010 Aug;5(4):325-33. Epub 2010 Apr 21.PMID: 20407848 4. Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, Prisco D, Poli D, Tripodi A, Palareti G; PROLONG Investigators; FCSA Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study. Italian Federation of Anticoagulation Clinics. Thromb Haemost. 2010 Jun;103(6):1152-60. 5. Eriksson BI, Turpie AG, Lassen MR, Prins MH, Agnelli G, Kälebo P, Wetherill G, Wilpshaar JW, Meems L; ONYX-2 STUDY GROUP Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2). J Thromb Haemost. 2010 Apr;8(4):714-21 6. Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G; PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics). Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. 7. Huth-Kühne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Lévesque H, Castellano ME, Shima M, St-Louis J. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009 Apr;94(4):566-75. 8. Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M, Tradati FC, Santagostino E, von Mackensen S; Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009 May;7(5):780-6. 9. Tiede A, Tait RC, Shaffer DW, Baudo F, Boneu B, Dempfle CE, Horellou MH, Klamroth R, Lazarchick J, Mumford AD, Schulman S, Shiach C, Bonfiglio LJ, Frieling JT, Conard J, von Depka M. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost. 2008 Mar;99(3):616-22. 10. Baudo F, de Cataldo F, Mostarda G, Ghirarduzzi A, Molinatti M, Pengo V, Poli D, Tosetto A, Tiraferri E, Morra E. Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics. Intern Emerg Med. 2007 Dec;2(4):280-4. 11. Redaelli R, Corno AR, Somaini MG, Gechtman C, Caimi TM, Baudo F, Morra E False incoagulable PT-INR results in oral anticoagulant therapy. Thromb Res. 2008;122(1):137-9. 12. Pengo V, Palareti G, Cucchini U, Molinatti M, Del Bono R, Baudo F, Ghirarduzzi A, Pegoraro C, Iliceto S; participating centers of Italian Federation of Anticoagulation Clinics (FCSA). Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP). Clin Appl Thromb Hemost. 2007 Jul;13(3):241-8. 13. Franchini M, Capra F, Nicolini N, Veneri D, Manzato F, Baudo F, Lippi G.Drug-induced anti-factor VIII antibodies: a systematic review. Med Sci Monit. 2007 Apr;13(4):RA55-61. 14. Baudo F. "Bridging" therapy in patients on long-term vitamin K antagonist treatment: a yet unsolved issue. Intern Emerg Med. 2006;1(2):94-5. 15. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006 Oct 26;355(17):1780-9. 16. Parodi O, De Chiara B, Baldassarre D, Parolini M, Caruso R, Pustina L, Parodi G, Campolo J, Sedda V, Baudo F, Sirtori C. Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction. Clin Biochem. 2007 Feb;40(3-4):188-93. 17. Campolo J, De Chiara B, Caruso R, De Maria R, Sedda V, Dellanoce C, Parolini M, Cighetti G, Penco S, Baudo F, Parodi O. Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia. Free Radic Res. 2006 Sep;40(9):929-35. 18. Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JC, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2006 Oct;4(10):2164-9. 19. De Gasperi A, Baudo F Use of recombinant factor VIIa during orthotopic liver transplantation. Liver 20. Baudo F, Caimi TM, Mostarda G, de Cataldo F, Morra E. Critical bleeding in pregnancy: a novel therapeutic approach to bleeding. Minerva Anestesiol. 2006 Jun;72(6):389-93. 21. Caruso R, Campolo J, Sedda V, De Chiara B, Dellanoce C, Baudo F, Tonini A, Parolini M, Cighetti G, Parodi O. Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia. J Cardiovasc Pharmacol. 2006 Apr;47(4):549-55. 22. Redaelli R, Corno AR, Borroni L, Mostarda G, Nichelatti M, Morra E, Baudo F. von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL) J Thromb Haemost. 2005 Dec;3(12):2684-8. 23. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005 Dec;3(12):2619-26. 24. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D'Angelo A, Tognoni G, Barbui T. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005 May;3(5):848-53. 25. De Gasperi A, Baudo F, De Carlis L. Recombinant FVII in orthotopic liver transplantation (OLT): a preliminary single centre experience. Intensive Care Med. 2005 Feb;31(2):315-6. Baudo F, de Cataldo F, Gaidano G; Italian registry of acquired hemophilia. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. Haematologica. 2004 Jun;89(6):759-61. 26. Baudo F, de Cataldo F, Gaidano G; Italian registry of acquired hemophilia Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. Haematologica. 2004 Jun;89(6):759-61. 27. Baudo F, de Cataldo F. Acquired hemophilia: a critical bleeding syndrome. Haematologica. 2004 28. Mafrici A, Baudo F. Hemophilia and percutaneous coronary interventions. Ital Heart J. 2003 29. Baudo F, de Cataldo F; Italian Association of Haemophilia Centres (AICE): Register of acquired factor VIII inhibitors (RIIA). Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice. BJOG. 2003 Mar;110(3):311-4. 30. Federici AB, Baudo F, Caracciolo C, Mancuso G, Mazzucconi MG, Musso R, Schinco PC, Targhetta R, Mannuccio Mannucci P Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi) in the treatment of von Willebrand disease: a retrospective clinical study. Haemophilia. 2002 Nov;8(6):761-7. 31. de Cataldo F, Baudo F.Successful treatment with 2-chlorodeoxyadenosine of secondary lesions of the central nervous system in low-grade lymphoid malignancies. Am J Hematol. 2002 Aug;70(4):332-3. 32. Baudo F. Coagulation and inflammation from therapy to practice Minerva Anestesiol. 2002 33. Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors. Thromb Haemost. 2001 Oct;86(4):954-8. 34. Baudo F, de Cataldo F. Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects . Minerva Anestesiol. 2000 Nov;66(11 Suppl 1):3-23. 35. Bellinazzo P, Silvello L, Caimi TM, Mostarda G, de Cataldo F, Baudo F. Long-term evaluation of a novel surgical approach to the pseudotumour of the ilium in haemophilia: exeresis and transposition of the omentum in the residual cavity. Haemophilia. 2000 Nov;6(6):702-4. 36. Baudo F, Redaelli R, Caimi TM, Mostarda G, Somaini G, de Cataldo F The continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complications. Thromb Res. 2000 Jul 1;99(1):21-4. 37. Baudo F, Caimi TM, Redaelli R, de Cataldo F, Somaini G, Rondinara GF, Degasperi A, Bellati G, Belli LS, Ideo G, Morfini M, Longo G. Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis. Haemophilia. 1999 Jul;5(4):276-7. 38. Giudici D, Baudo F, Palareti G, Ravizza A, Ridolfi L, D' Angelo A. Antithrombin replacement in patients with sepsis and septic shock. Haematologica. 1999 May;84(5):452-60. 39. Baudo F, Caimi TM, de Cataldo F, Calori G. Antithrombin III in intensive therapy Minerva Anestesiol. 1999 Jan-Feb;65(1-2 Suppl 1):71-6. 40. Baudo F, Redaelli R, de Cataldo F. General classification of hemostasis Minerva Anestesiol. 1999 41. Bucciarelli P, Rosendaal FR, Tripodi A, Mannucci PM, De Stefano V, Palareti G, Finazzi G, Baudo F, Quintavalla R Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1026-33. 42. Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Blood Coagul Fibrinolysis. 1999 Mar;10(2):93-9. 43. Baudo F, Caimi TM, de Cataldo F, Ravizza A, Arlati S, Casella G, Carugo D, Palareti G, Legnani C, Ridolfi L, Rossi R, D'Angelo A, Crippa L, Giudici D, Gallioli G, Wolfler A, Calori G Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med. 1998 Apr;24(4):336-42. 44. Cirasino L, Guatteri A, Sandri L, Baudo F, Silvani A, Morra MALT lymphoma of the left lacrimal and mammary glands, liver cirrhosis caused by HCV and type II cryoglobulinemia Recenti Prog Med. 1998 Feb;89(2):79-81. 45. Complete regression of a suprasellar secondary mass in a patient with low-grade non-Hodgkin's lymphoma (NHL) treated with 2-chlorodeoxyadenosine (CdA) de Cataldo F, Baudo F, Ottonelli C, Italia C, Valdagni R. Am J Hematol. 1998 Mar;57(3):258-9. 46. Finazzi G, Brancaccio V, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D'Angelo A, Palareti G, De Stefano V, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med. 1996 May;100(5):530-6. 47. de Cataldo F, Baudo F, Redaelli R, Corno AR. Abnormal platelet von Willebrand factor (vWF) as a marker of abnormal function in megakaryocytic dysplasia. Am J Hematol. 1995 Mar;48(3):155-7. 48. Arcieri R, Puopolo M, Baudo F, Chiarotti F, De Rosa V, Schinaia N, Mori PG, Ghirardini A. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies. Haematologica. 1995 Jan-Feb;80(1):25-30. 49. Furlan M, Steinmann C, Jungo M, Bögli C, Baudo F, Redaelli R, Fedeli F, Lämmle B. A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III. J Biol Chem. 1994 Dec 30;269(52):33129-34. 50. Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M. A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization. Blood. 1994 Sep 15;84(6):1874-80. 51. Steinmann C, Bögli C, Jungo M, Lämmle B, Heinemann G, Wermuth B, Redaelli R, Baudo F, Furlan M. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution. Blood Coagul Fibrinolysis. 1994 Aug;5(4):463-71. 52. Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery. Thromb Haemost. 1994 Jun;71(6):737-40. 53. Brucato A, Baudo F, Barberis M, Redaelli R, Casadei G, Allegri F, De Juli E, de Cataldo F. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J Rheumatol. 1994 May;21(5):942-4. 54. de Cataldo F, Cairoli R, Baudo F, Pezzetti L, Lo Cunsolo CL, Perutelli P, Mori PG. Abnormalities of cytoskeletal proteins of the red blood cells in myelodysplastic syndromes. Int J Hematol. 1994 Apr;59(3):227-9. 55. Bernardi F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M, Redaelli R, Baudo F, Mariani G, Marchetti G. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum Genet. 1993 Nov;92(5):446-50. 56. Mosca A, Paleari R, Rubino FM, Zecca L, De Bellis G, Debernardi S, Baudo F, Cappellini D, Fiorelli G. Hb Abruzzo [beta 143(H21)His-->Arg] identified by mass spectrometry and DNA analysis. Hemoglobin. 1993 Jun;17(3):261-8. 57. Acquila M, Caprino D, Pecorara M, Baudo F, Morfini M, Mori PG. Two novel mutations at 373 codon of FVIII gene detected by DGGE. Thromb Haemost. 1993 Apr 1;69(4):392-3. 58. Baudo F, Brambilla G, de Cataldo F, Rampoldi A. Local thrombolysis with recombinant tissue plasminogen activator in a high-risk patient. Lancet. 1993 Jan 2;341(8836):64. 59. Baudo F, DeGasperi A, de Cataldo F, Caimi TM, Cattaneo D, Redaelli R, Pannacciulli E, Corti A, Mazza E, Belli L. Antithrombin III supplementation during orthotopic liver transplantation in cirrhotic patients: a randomized trial. Thromb Res. 1992 Dec 1;68(4-5):409-16. 60. Mannucci PM, Gringeri A, de Biasi R, Baudo F, Morfini M, Ciavarella N. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate. Thromb Haemost. 1992 Mar 2;67(3):310-3. 61. Mannucci PM, Tripodi A, Bottasso B, Baudo F, Finazzi G, De Stefano V, Palareti G, Manotti C, Mazzucconi MG, Castaman G. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost. 1992 Feb 3;67(2):200-2. 62. Pezzetti L, Redaelli R, Caimi TM, Cattaneo D, Baudo F, de Cataldo F. The multimeric pattern of von Willebrand's factor (vWF) can be demonstrated also in the severe form of the disease. Int J Hematol. 1992 Feb;55(1):89-91. 63. de Cataldo F, Baudo F, Redaelli R, Pezzetti L, Marenco P, Cattaneo D. Abnormal multimeric pattern of platelet von Willebrand factor (VWF) in a case of myelodysplastic syndrome (MDS) and its normalization in remission. Am J Hematol. 1992 Feb;39(2):151-2. 64. Bögli C, Hofer A, Baudo F, Redaelli R, Furlan M. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His). Haemostasis. 1992;22(1):7-11. 65. Baudo F, De Gasperi A, Belli L, de Cataldo F. Antithrombin III, blood loss, and transfusion requirements during liver transplantation. Lancet. 1991 Oct 5;338(8771):897-8. 66. Caimi MT, Redaelli R, Cattaneo D, Nosari AM, Baudo F, de Cataldo F. Acquired selective factor X deficiency in acute nonlymphocytic leukemia. Am J Hematol. 1991 Jan;36(1):65-6. 67. Baudo F, Caimi TM, Redaelli R, Nosari AM, Mauri M, Leonardi G, de Cataldo F. Emergency treatment with recombinant tissue plasminogen activator of pulmonary embolism in a pregnant woman with antithrombin III deficiency. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1274-5. 68. Baudo F, Caimi MT, Redaelli R, Cattaneo D, De Gasperi A, Belli L, de Cataldo F. Substitution therapy with antithrombin III in orthotopic liver transplantation: possible effect on hemorrhage reduction. Haematologica. 1990 Mar-Apr;75 Suppl 2:41-9. 69. Casula L, Murru S, Pecorara M, Ristaldi MS, Restagno G, Mancuso G, Morfini M, De Biasi R, Baudo F, Carbonara A, et al. Recurrent mutations and three novel rearrangements in the factor VIII gene of hemophilia A patients of Italian descent. Blood. 1990 Feb 1;75(3):662-70. 70. Baudo F, Redaelli R, Pezzetti L, Caimi TM, Busnach G, Perrino L, de Cataldo F. Prothrombin- antibody coexistent with lupus anticoagulant (LA): clinical study and immunochemical characterization. Thromb Res. 1990 Jan 15;57(2):279-87. 71. Bellinazzo P, Silvello L, Caimi MT, Baudo F, de Cataldo F. Novel surgical approach to pseudotumour of ilium in haemophilia. Lancet. 1989 Dec 2;2(8675):1333-4. 72. Longo G, Messori A, Morfini M, Baudo F, Ciavarella N, Cinotti S, Filimberti E, Giustarini G, Molinari AC, Ferrini PR. Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations. Am J Hematol. 1989 Mar;30(3):140-9. 73. Mannucci PM, Gringeri A, Morfini M, De Biasi R, Tirindelli MC, Tamponi G, Baudo F, Carnelli V, Ciavarella N, Colombo M, et al. Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs. Am J Hematol. 1988 Dec;29(4):211-4. 74. Baudo F, de Cataldo F, Landonio G, Muti G . Management of oral bleeding in haemophilic patients. 75. Landonio G, Nosari AM, Barbarano L, Muti G, Panzacchi G, Baudo F, Cipriani D, de Cataldo F. Splenectomy for severe HIV-related thrombocytopenia in heroin abusers. Br J Haematol. 1988 Jun;69(2):290. 76. Redaelli R, Pezzetti L, Caimi T, Baudo F, de Cataldo F. Severe von Willebrand's disease: SDS agarose multimer analysis. Haemostasis. 1987;17(5):278-85. 77. Baudo F, de Cataldo F, Gatti R, Landonio G, Muti G, Scolari G. Local hemostasis after tooth extraction in patients with abnormal hemostatic function. Use of human fibrinogen concentrate. Haemostasis. 1985;15(6):402-4. 78. de Cataldo F, Baudo F, Redaelli R, Pezzetti L. Acquired factor VIII:C inhibitor (IgG) and positive direct Coombs' test (IgM) in a patient with lung carcinoma. Clinical course and immunochemical studies. Scand J Haematol. 1984 Aug;33(2): 171-6 79. Gatti R, Zerbini A, Landonio G, Baudo F. Clinical use, effects and results of fibrin glue in dentistry. Riv Ital Stomatol. 1983 Oct;52(10):781-6. 80. Scarponi R, Silvello L, Landonio G, Baudo F, de Cataldo F. Long-term evaluation of knee-joint function after synovectomy in haemophilia. Br J Haematol. 1982 Oct;52(2):337-8. 81. de Cataldo F, Baudo F. Plasma factors and thrombasthenic platelets. Br J Haematol. 1981 82. de Cataldo F, Baudo F. Sensitization of stabilized fibrin to urea dispersion by undiluted plasma and 83. Strinchini A, Baudo F, Nosari AM, Panzacchi G, de Cataldo F. Defibrination and head injury. Lancet. 84. Bussi L, Silvello L, Baudo F, de Cataldo F. Results of synovectomy of the knee in haemophilia. 85. de Cataldo F, Baudo F. Physiological inhibition of factor XIII. Ann N Y Acad Sci. 1972 Dec 86. Baudo F, de Cataldo F, Josso F, Silvello L. Hereditary hypoprothrombinaemia. True deficiency of factor II. Acta Haematol. 1972;47(4):243-9. 87. Baudo F, Ghessi A, de Cataldo F. Clinical experience in the hemorrhagic disease (1964-1969. 88. de Cataldo F, Baudo F. Physiological inhibiting activity of factor XIII. Haematol Lat. 1969 Jul- 89. de Cataldo F, Baudo F, Bussi L. Factor XIII-inhibitory activity of normal plasma and cysteine. 90. Bandi GL, Baudo F, Giovannini U. The absorption of orally administered tetracycline in association with pancreatic proteolytic enzymes. Farmaco Prat. 1968 Sep;23(9):491-9. 91. de Cataldo F, Baudo F, Strinchini A, Bussi L. Physiological inhibition of factor VIII. Lancet. 1968 Apr 92. Baudo F, Camera G, Cipriani D, de Cataldo F, Pensabene A, Tiso R, Bussi L. Daunomycin-- preliminary results of the treatment of acute leukemias in adults. Oncology. 1968;22(1):67-73. 93. Baudo F, Cipriani D, de Cataldo F, Ladelli G, Pensabene A. Coagulation disorders with comsumption of coagulation factors, probably due to drug hypersensitivity. Minerva Med. 1967 Dec 15;58(100):4618-20. 94. de Cataldo F, Torelli D, Baudo F. Relative erythrocythemia associated with chronic glomerulonephritis. Haematol Lat. 1967 Oct-Dec;10(4):391-3. 95. Baudo F, Cattaneo N, Cipriani D, de Cataldo F, Pensabene A, Tiso R. Clinical trial of hydroxyurea in chronic myelocytic leukemia. Haematol Lat. 1967 Oct-Dec;10(4):359-62. 96. de Cataldo F, Baudo F. 'Pitfalls' of Factor VIII assay. Acta Haematol. 1967;38(6):383-7. 97. Bussi L, Greco O, Baudo F. Experimental research on the erythropoietic activity of lyophilized serum of the plurivenesectomized horse. Haematol Lat. 1964 Jan-Mar;7:1-8.


Draft – zest quest outcomes/grade level indicators

Draft – Zest Quest Outcomes/Grade Level Indicators Outcome 1: By the end of fifth grade, students will describe the effects of the Zest Quest Seven Daily Healthy Habits (ZQSDHH) on wellness and accessing valid resources (content, accessing valid resources). SC Hlth Stds. 1, 2 Grade K: K.1.A: Identify healthy and unhealthy behaviors. K.1.C: Differentiate between active a

Das Kopieren der Leseproben ist nicht gestattet. Tel. +49 7626 9749 700Fax +49 7626 9749 709und englischen Homöopathie Bücher vorgestellt. ist ein Verlag für Homöopathie Bücher. Wir publizieren Werke von hochkarätigen innovativen Autoren wie , , , , , , , , , veranstaltet begeistern bis zu 300 Teilnehmer. ➤ Myristica sebifera D 3 (Muskatnussbaum): Das Mittel hat die eitrige Ei

Copyright © 2010-2019 Pdf Physician Treatment